Ptch1- or Smo-activated Hematologic Tumors
📧 Sign up to get email alerts when something new happens for Ptch1- or Smo-activated Hematologic Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-02Clinical Trial Update: LDE225 for Patients With PTCH1 or SMO Mutated Tumors [Phase 2]
A Phase 2 study of LDE225 (sonidegib) for PTCH1- or SMO-activated solid and hematologic tumors was terminated; results were posted on 2016-0…